Rybelsus (semaglutide)瑞倍适/瑞倍適

价　　格：¥0
货　　号：NTCC®-Rybelsus
产　　地：北京

竭诚为您服务！

BioVector NTCC典型培养物保藏中心: 联系人：Dr.Xu, Biovector NTCC Inc.; 电话：400-800-2947 工作微信:1843439339 (QQ同号); 邮件：Biovector@163.com; 手机：18901268599; 地址：北京; 已注册

详细信息
咨询记录(共0条)

Rybelsus (semaglutide) is an oral, once-daily prescription tablet designed for type 2 diabetes that often causes significant weight loss by slowing digestion and reducing appetite. While approved for blood sugar control, it is sometimes used off-label for weight management (BMI >30, or >27 with conditions). It requires strict, empty-stomach morning dosing.

Key Facts About Rybelsus for Weight Loss:

Active Ingredient: Contains semaglutide, the same active ingredient as weight-loss injections Wegovy and Ozempic.
Mechanism: As a GLP-1 receptor agonist, it slows gastric emptying, making you feel fuller for longer, thus reducing calorie intake.
Effectiveness: Studies indicate that 50mg daily doses could result in up to 17.4% weight loss, although standard dosages (7mg/14mg) are lower.
How to Take: Take on an empty stomach immediately upon waking with a small sip of water (max 120ml). Wait at least 30 minutes before eating, drinking, or taking other medications.
Side Effects: Common side effects include nausea, vomiting, diarrhea, stomach pain, and constipation.
Dosage: Available in 3mg, 7mg, and 14mg doses, often starting lower to build tolerance.